APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Organoids

Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:

Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.

Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.

Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.

Selected research

Market Outlook & Growth Opportunities

Global Organoids Market Outlook and Growth Opportunities 2026

Report ID 173917560428 December 2025191 pages

Choose your research edition.

Industry ResearchOrganoids Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Organoids Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Organoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Organoids Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Organoids Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:

Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.

Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.

Read the full market overview

Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.

From perspective of type, organoids can be split into 3D Organoid Culture, Biochemical Cues and others. In 2018, D3D Organoid Culture took accounted for nearly 71%, which made it the largest segment of global organoids.

North America is the largest consumption region of organoids, with a consumption market share nearly 46% in 2019. The second place is Europe; following North America with the consumption market share over 40% in 2019.

Key manufacturers of global organoids market are Thermo Fisher Scientific, Merck and Corning. The top 3 players totally took up a market share of about 75% in 2019. Thermo Fisher Scientific is in the first place, which accounted for above 34% of global market.

This report provides an overview of the global Organoids market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Organoids and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Organoids revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Organoids market.

Organoids Segment by Company

Thermo Fisher Scientific

Merck

Corning

STEMCELL Technologies

Lonza

Prellis Biologics

amsbio

Cellesce

DefiniGEN

OcellO B.V.

HUB Oranoid Technology

3Dnamics Inc.

Organoid Therapeutics

InSphero

Organoids Segment by Type

3D Organoid Culture

Biochemical Cues

Organoids Segment by Application

Biopharmaceutical Companies

Contract Research Organizations

Academics and Research Institutes

Organoids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Organoids status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Organoids key companies, revenue, market share, and recent developments.

3. To split the Organoids breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Organoids market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Organoids significant trends, drivers, influence factors in global and regions.

6. To analyze Organoids competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Organoids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organoids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Organoids industry.

Chapter 3: Detailed analysis of Organoids company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Organoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Organoids in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Organoids Industry Trends Table 2. Organoids Industry Drivers Table 3. Organoids Industry Opportunities and Challenges Table 4. Organoids Industry Restraints Table 5. Global Organoids Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Organoids Revenue Share by Company (2021-2026) Table 7. Global Organoids Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Organoids Key Company Manufacturing Base & Headquarters Table 9. Global Organoids Company, Product Type & Application Table 10. Global Organoids Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Organoids by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 3D Organoid Culture Table 15. Significant Companies of Biochemical Cues Table 16. Global Organoids Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Organoids Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Organoids Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Organoids Sales Value Share by Type (2021-2026) Table 20. Global Organoids Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Biopharmaceutical Companies Table 22. Significant Companies of Contract Research Organizations Table 23. Significant Companies of Academics and Research Institutes Table 24. Global Organoids Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Organoids Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Organoids Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Organoids Sales Value Share by Application (2021-2026) Table 28. Global Organoids Sales Value Share by Application (2027-2032) Table 29. Global Organoids Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Organoids Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Organoids Sales Value Share by Region (2021-2026) Table 32. Global Organoids Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Organoids Sales Value Share by Region (2027-2032) Table 34. Global Organoids Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Organoids Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Organoids Sales Value Market Share by Country (2021-2026) Table 37. Global Organoids Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Organoids Sales Value Market Share by Country (2027-2032) Table 39. Thermo Fisher Scientific Company Information Table 40. Thermo Fisher Scientific Business Overview Table 41. Thermo Fisher Scientific Organoids Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Thermo Fisher Scientific Organoids Product Portfolio Table 43. Thermo Fisher Scientific Recent Development Table 44. Merck Company Information Table 45. Merck Business Overview Table 46. Merck Organoids Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Merck Organoids Product Portfolio Table 48. Merck Recent Development Table 49. Corning Company Information Table 50. Corning Business Overview Table 51. Corning Organoids Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Corning Organoids Product Portfolio Table 53. Corning Recent Development Table 54. STEMCELL Technologies Company Information Table 55. STEMCELL Technologies Business Overview Table 56. STEMCELL Technologies Organoids Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. STEMCELL Technologies Organoids Product Portfolio Table 58. STEMCELL Technologies Recent Development Table 59. Lonza Company Information Table 60. Lonza Business Overview Table 61. Lonza Organoids Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Lonza Organoids Product Portfolio Table 63. Lonza Recent Development Table 64. Prellis Biologics Company Information Table 65. Prellis Biologics Business Overview Table 66. Prellis Biologics Organoids Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Prellis Biologics Organoids Product Portfolio Table 68. Prellis Biologics Recent Development Table 69. amsbio Company Information Table 70. amsbio Business Overview Table 71. amsbio Organoids Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. amsbio Organoids Product Portfolio Table 73. amsbio Recent Development Table 74. Cellesce Company Information Table 75. Cellesce Business Overview Table 76. Cellesce Organoids Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Cellesce Organoids Product Portfolio Table 78. Cellesce Recent Development Table 79. DefiniGEN Company Information Table 80. DefiniGEN Business Overview Table 81. DefiniGEN Organoids Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. DefiniGEN Organoids Product Portfolio Table 83. DefiniGEN Recent Development Table 84. OcellO B.V. Company Information Table 85. OcellO B.V. Business Overview Table 86. OcellO B.V. Organoids Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. OcellO B.V. Organoids Product Portfolio Table 88. OcellO B.V. Recent Development Table 89. HUB Oranoid Technology Company Information Table 90. HUB Oranoid Technology Business Overview Table 91. HUB Oranoid Technology Organoids Sales (), Value (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 92. HUB Oranoid Technology Organoids Product Portfolio Table 93. HUB Oranoid Technology Recent Development Table 94. 3Dnamics Inc. Company Information Table 95. 3Dnamics Inc. Business Overview Table 96. 3Dnamics Inc. Organoids Sales (), Value (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 97. 3Dnamics Inc. Organoids Product Portfolio Table 98. 3Dnamics Inc. Recent Development Table 99. Organoid Therapeutics Company Information Table 100. Organoid Therapeutics Business Overview Table 101. Organoid Therapeutics Organoids Sales (), Value (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 102. Organoid Therapeutics Organoids Product Portfolio Table 103. Organoid Therapeutics Recent Development Table 104. InSphero Company Information Table 105. InSphero Business Overview Table 106. InSphero Organoids Sales (), Value (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 107. InSphero Organoids Product Portfolio Table 108. InSphero Recent Development Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Organoids Product Image Figure 2. Global Organoids Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Organoids Market Size (2021-2032) & (US$ Million) Figure 4. Global Organoids Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 3D Organoid Culture Image Figure 8. Biochemical Cues Image Figure 9. Global Organoids Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Organoids Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Organoids Sales Value Share by Type (2021-2032) Figure 12. Biopharmaceutical Companies Image Figure 13. Contract Research Organizations Image Figure 14. Academics and Research Institutes Image Figure 15. Global Organoids Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Organoids Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Organoids Sales Value Share by Application (2021-2032) Figure 18. Global Organoids Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Organoids Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Organoids Sales Value (2021-2032) & (US$ Million) Figure 21. North America Organoids Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Organoids Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Organoids Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Organoids Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Organoids Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Organoids Sales Value (2021-2032) & (US$ Million) Figure 27. South America Organoids Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Organoids Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Organoids Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Organoids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Organoids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Organoids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • 3D Organoid Culture
  • Biochemical Cues
Applications
  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Academics and Research Institutes
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • Corning
  • STEMCELL Technologies
  • Lonza
  • Prellis Biologics
  • amsbio
  • Cellesce
  • DefiniGEN
  • OcellO B.V.
  • HUB Oranoid Technology
  • 3Dnamics Inc.
  • Organoid Therapeutics
  • InSphero

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Organoids Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Organoids Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Organoids Market Dynamics
  1. 2.1 Organoids Industry Trends
  2. 2.2 Organoids Industry Drivers
  3. 2.3 Organoids Industry Opportunities and Challenges
  4. 2.4 Organoids Industry Restraints
3 Organoids Market by Company
  1. 3.1 Global Organoids Company Revenue Ranking in 2025
  2. 3.2 Global Organoids Revenue by Company (2021-2026)
  3. 3.3 Global Organoids Company Ranking (2024-2026)
  4. 3.4 Global Organoids Company Manufacturing Base and Headquarters
  5. 3.5 Global Organoids Company Product Type and Application
  6. 3.6 Global Organoids Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Organoids Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Organoids Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Organoids Market by Type
  1. 4.1 Organoids Type Introduction
  2. 4.1.1 3D Organoid Culture
  3. 4.1.2 Biochemical Cues
  4. 4.2 Global Organoids Sales Value by Type
  5. 4.2.1 Global Organoids Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Organoids Sales Value by Type (2021-2032)
  7. 4.2.3 Global Organoids Sales Value Share by Type (2021-2032)
5 Organoids Market by Application
  1. 5.1 Organoids Application Introduction
  2. 5.1.1 Biopharmaceutical Companies
  3. 5.1.2 Contract Research Organizations
  4. 5.1.3 Academics and Research Institutes
  5. 5.2 Global Organoids Sales Value by Application
  6. 5.2.1 Global Organoids Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Organoids Sales Value by Application (2021-2032)
  8. 5.2.3 Global Organoids Sales Value Share by Application (2021-2032)
6 Organoids Regional Value Analysis
  1. 6.1 Global Organoids Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Organoids Sales Value by Region (2021-2032)
  3. 6.2.1 Global Organoids Sales Value by Region: 2021-2026
  4. 6.2.2 Global Organoids Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Organoids Sales Value (2021-2032)
  7. 6.3.2 North America Organoids Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Organoids Sales Value (2021-2032)
  10. 6.4.2 Europe Organoids Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Organoids Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Organoids Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Organoids Sales Value (2021-2032)
  16. 6.6.2 South America Organoids Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Organoids Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Organoids Sales Value Share by Country, 2025 VS 2032
7 Organoids Country-level Value Analysis
  1. 7.1 Global Organoids Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Organoids Sales Value by Country (2021-2032)
  3. 7.2.1 Global Organoids Sales Value by Country (2021-2026)
  4. 7.2.2 Global Organoids Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Organoids Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Organoids Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Organoids Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Organoids Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Organoids Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Organoids Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Organoids Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Organoids Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Organoids Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Organoids Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Organoids Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Organoids Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Organoids Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Organoids Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Organoids Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Organoids Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Organoids Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Organoids Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Organoids Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Organoids Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Organoids Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Organoids Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Organoids Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Organoids Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Organoids Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Organoids Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Organoids Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Organoids Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Organoids Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Organoids Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Organoids Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Organoids Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Organoids Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Organoids Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Organoids Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Organoids Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Organoids Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Organoids Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Organoids Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Organoids Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Organoids Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Organoids Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Organoids Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Organoids Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Organoids Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Organoids Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Organoids Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Organoids Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Organoids Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Organoids Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Organoids Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Organoids Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Organoids Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Organoids Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Organoids Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Organoids Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Organoids Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Organoids Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Organoids Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Organoids Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Organoids Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Organoids Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Organoids Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Organoids Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Organoids Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Organoids Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Organoids Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Organoids Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Organoids Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Organoids Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Organoids Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Organoids Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Organoids Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Organoids Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Organoids Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Organoids Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Organoids Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Organoids Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Organoids Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Organoids Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Organoids Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Organoids Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Organoids Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Organoids Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Organoids Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Organoids Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Organoids Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Organoids Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Corning
  14. 8.3.1 Corning Company Information
  15. 8.3.2 Corning Business Overview
  16. 8.3.3 Corning Organoids Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Corning Organoids Product Portfolio
  18. 8.3.5 Corning Recent Developments
  19. 8.4 STEMCELL Technologies
  20. 8.4.1 STEMCELL Technologies Company Information
  21. 8.4.2 STEMCELL Technologies Business Overview
  22. 8.4.3 STEMCELL Technologies Organoids Revenue and Gross Margin (2021-2026)
  23. 8.4.4 STEMCELL Technologies Organoids Product Portfolio
  24. 8.4.5 STEMCELL Technologies Recent Developments
  25. 8.5 Lonza
  26. 8.5.1 Lonza Company Information
  27. 8.5.2 Lonza Business Overview
  28. 8.5.3 Lonza Organoids Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lonza Organoids Product Portfolio
  30. 8.5.5 Lonza Recent Developments
  31. 8.6 Prellis Biologics
  32. 8.6.1 Prellis Biologics Company Information
  33. 8.6.2 Prellis Biologics Business Overview
  34. 8.6.3 Prellis Biologics Organoids Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Prellis Biologics Organoids Product Portfolio
  36. 8.6.5 Prellis Biologics Recent Developments
  37. 8.7 amsbio
  38. 8.7.1 amsbio Company Information
  39. 8.7.2 amsbio Business Overview
  40. 8.7.3 amsbio Organoids Revenue and Gross Margin (2021-2026)
  41. 8.7.4 amsbio Organoids Product Portfolio
  42. 8.7.5 amsbio Recent Developments
  43. 8.8 Cellesce
  44. 8.8.1 Cellesce Company Information
  45. 8.8.2 Cellesce Business Overview
  46. 8.8.3 Cellesce Organoids Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cellesce Organoids Product Portfolio
  48. 8.8.5 Cellesce Recent Developments
  49. 8.9 DefiniGEN
  50. 8.9.1 DefiniGEN Company Information
  51. 8.9.2 DefiniGEN Business Overview
  52. 8.9.3 DefiniGEN Organoids Revenue and Gross Margin (2021-2026)
  53. 8.9.4 DefiniGEN Organoids Product Portfolio
  54. 8.9.5 DefiniGEN Recent Developments
  55. 8.10 OcellO B.V.
  56. 8.10.1 OcellO B.V. Company Information
  57. 8.10.2 OcellO B.V. Business Overview
  58. 8.10.3 OcellO B.V. Organoids Revenue and Gross Margin (2021-2026)
  59. 8.10.4 OcellO B.V. Organoids Product Portfolio
  60. 8.10.5 OcellO B.V. Recent Developments
  61. 8.11 HUB Oranoid Technology
  62. 8.11.1 HUB Oranoid Technology Company Information
  63. 8.11.2 HUB Oranoid Technology Business Overview
  64. 8.11.3 HUB Oranoid Technology Organoids Revenue and Gross Margin (2021-2026)
  65. 8.11.4 HUB Oranoid Technology Organoids Product Portfolio
  66. 8.11.5 HUB Oranoid Technology Recent Developments
  67. 8.12 3Dnamics Inc.
  68. 8.12.1 3Dnamics Inc. Company Information
  69. 8.12.2 3Dnamics Inc. Business Overview
  70. 8.12.3 3Dnamics Inc. Organoids Revenue and Gross Margin (2021-2026)
  71. 8.12.4 3Dnamics Inc. Organoids Product Portfolio
  72. 8.12.5 3Dnamics Inc. Recent Developments
  73. 8.13 Organoid Therapeutics
  74. 8.13.1 Organoid Therapeutics Company Information
  75. 8.13.2 Organoid Therapeutics Business Overview
  76. 8.13.3 Organoid Therapeutics Organoids Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Organoid Therapeutics Organoids Product Portfolio
  78. 8.13.5 Organoid Therapeutics Recent Developments
  79. 8.14 InSphero
  80. 8.14.1 InSphero Company Information
  81. 8.14.2 InSphero Business Overview
  82. 8.14.3 InSphero Organoids Revenue and Gross Margin (2021-2026)
  83. 8.14.4 InSphero Organoids Product Portfolio
  84. 8.14.5 InSphero Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst